Table 2.

Distribution of EQ-5D, EORTC QLQ-C30 and EORTC QLQ-MY20 scores

	No. of patients	Mean ± SD	Median	Interquartile range
EQ-5D	154	0.7 ± 0.3	0.73	0.62–1.00
EORTC QLQ-C30
Global health status/QoL	154	60.1 ± 25.5	58.3	41.7–83.3
Functional scales
Physical	154	68.7 ± 27.2	73.3	53.3–93.3
Role	153	62.9 ± 34.6	66.7	33.3–100.0
Emotional	154	78.1 ± 24.6	83.3	66.7–100.0
Cognitive	154	81.4 ± 22.9	83.3	66.7–100.0
Social	154	63.9 ± 32.9	66.7	33.3–100.0
Symptom scales
Fatigue	154	38.6 ± 29.8	33.3	11.1–66.7
Nausea/Vomiting	154	5.2 ± 11.8	0.0	0.0–0.0
Pain	154	32.3 ± 33.4	16.7	0.0–66.7
Single items
Dyspnea	154	21.9 ± 30.6	0.0	0.0–33.3
Insomnia	154	25.1 ± 29.8	16.7	0.0–33.3
Appetite Loss	154	15.4 ± 27.0	0.0	0.0–33.3
Constipation	154	17.7 ± 28.6	0.0	0.0–33.3
Diarrhea	154	8.4 ± 21.7	0.0	0.0–0.0
Financial difficulties	154	18.4 ± 31.2	0.0	0.0–33.3
EORTC QLQ-MY20
Disease symptoms	154	23.3 ± 22.3	16.7	0.0–38.9
Side-effects of treatment	154	19.5 ± 17.1	14.8	7.4–29.6
Future perspective	154	59.9 ± 28.1	66.7	33.3–77.8
Body image	154	77.9 ± 30.5	100.0	66.7–100.0

SD standard deviation.